Summary
This 10-K/A filing for Johnson & Johnson (JNJ) covers the fiscal year ended December 28, 2002, and serves as an amendment to their annual report. The filing confirms JNJ's status as a well-established, publicly traded entity with its common stock listed on the New York Stock Exchange. A significant point for investors is the substantial market capitalization, with the aggregate market value of non-affiliate shares exceeding $156 billion as of June 28, 2002, underscoring the company's immense scale and investor confidence. The company has met its reporting obligations, filing all required reports for the preceding 12 months and adhering to filing requirements for the past 90 days. This amendment, filed on June 25, 2003, provides updated or supplementary information related to the 2002 fiscal year. Investors should note that key operational details and financial performance figures for 2002 would typically be found within the referenced annual report to shareowners and the proxy statement for the 2003 annual meeting.
Key Highlights
- 1Johnson & Johnson (JNJ) filed an amendment (10-K/A) to its annual report for the fiscal year ended December 28, 2002.
- 2The company's common stock is listed and traded on the New York Stock Exchange.
- 3As of June 28, 2002, the aggregate market value of JNJ's non-affiliate shares was approximately $156 billion, indicating a very large market capitalization.
- 4JNJ has complied with SEC filing requirements, having filed all necessary reports for the preceding 12 months and the past 90 days.
- 5The filing date for this amendment was June 25, 2003.
- 6The company has 2,969,972,365 shares of Common Stock outstanding as of February 25, 2003.
- 7Key details of the annual report are incorporated by reference from the 2002 annual report to shareowners and the 2003 proxy statement.